Brain GLP-1 and insulin sensitivity

Molecular and Cellular Endocrinology

Volumn 418, Issue , 2015, Pages 27-32

  Sandoval, Darleen ^a   Sisley, Stephanie R ^b  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Brain; GLP 1; GLP 1R; Glucagon like peptide 1; Glucose; Insulin sensitivity

Indexed keywords

EXENDIN 4; GLUCAGON LIKE PEPTIDE 1; GLUCAGON LIKE PEPTIDE 1 DERIVATIVE; GLUCAGON LIKE PEPTIDE 1 RECEPTOR; GLUCOSE; INSULIN; LIRAGLUTIDE;

BLOOD GLUCOSE MONITORING; BRAIN FUNCTION; DRUG EFFECT; GLUCONEOGENESIS; GLUCOSE CLAMP TECHNIQUE; GLUCOSE HOMEOSTASIS; GLUCOSE TOLERANCE; GLUCOSE TRANSPORT; HORMONE ACTION; HUMAN; HYPERGLYCEMIA; INSULIN BLOOD LEVEL; INSULIN RESPONSE; INSULIN SENSITIVITY; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; REVIEW; STRESS; WEIGHT REDUCTION; ANIMAL; BRAIN; HOMEOSTASIS; INSULIN RESISTANCE; METABOLISM; PHYSIOLOGY;

ANIMALS; BRAIN; GLUCAGON-LIKE PEPTIDE 1; GLUCOSE; HOMEOSTASIS; HUMANS; INSULIN; INSULIN RESISTANCE; INSULIN-SECRETING CELLS;

EID: 84946786725     PISSN: 03037207     EISSN: 18728057     Source Type: Journal    
DOI: 10.1016/j.mce.2015.02.017     Document Type: Review

References (51)

1. Ayala J.E., et al. The glucagon-like peptide-1 receptor regulates endogenous glucose production and muscle glucose uptake independent of its incretin action. Endocrinology 2009, 150:1155-1164.
2. Baggio L.L., Drucker D.J. Biology of incretins: GLP-1 and GIP. Gastroenterology 2007, 132:2131-2157.
3. Baggio L.L., Huang Q., Cao X., Drucker D.J. An albumin-exendin-4 conjugate engages central and peripheral circuits regulating murine energy and glucose homeostasis. Gastroenterology 2008, 134:1137-1147.
4. Barrera J.G., et al. Hyperphagia and increased fat accumulation in two models of chronic CNS glucagon-like peptide-1 loss of function. J. Neurosci 2011, 31:3904-3913.
5. Best J.D., et al. Role of glucose effectiveness in the determination of glucose tolerance. Diabetes Care 1996, 19:1018-1030.
6. Bielohuby M., et al. Impaired glucose tolerance in rats fed low-carbohydrate, high-fat diets. Am. J. Physiol. Endocrinol. Metab 2013, 305:E1059-E1070.
7. Burmeister M.A., et al. Acute activation of central GLP-1 receptors enhances hepatic insulin action and insulin secretion in high-fat-fed, insulin resistant mice. Am. J. Physiol. Endocrinol. Metab 2012, 302:E334-E343.
8. Buse J.B., et al. Exenatide once weekly versus liraglutide once daily in patients with type 2 diabetes (DURATION-6): a randomised, open-label study. Lancet 2013, 381:117-124.
9. Cabou C., et al. Brain glucagon-like peptide-1 regulates arterial blood flow, heart rate, and insulin sensitivity. Diabetes 2008, 57:2577-2587.
10. Cabou C., Vachoux C., Campistron G., Drucker D.J., Burcelin R., Brain G.L.P. 1 signaling regulates femoral artery blood flow and insulin sensitivity through hypothalamic PKC-δ. Diabetes 2011, 60:2245-2256.
11. Campbell J.E., Drucker D.J. Pharmacology, physiology, and mechanisms of incretin hormone action. Cell Metab 2013, 17:819-837.
12. Chan H.M., Jain R., Ahrén B., Pacini G., D'Argenio D.Z. Effects of increasing doses of glucagon-like peptide-1 on insulin-releasing phases during intravenous glucose administration in mice. Am. J. Physiol. Regul. Integr. Comp. Physiol 2011, 300:R1126-R1133.
13. Cobelli C., et al. Assessment of beta-cell function in humans, simultaneously with insulin sensitivity and hepatic extraction, from intravenous and oral glucose tests. Am. J. Physiol. Endocrinol. Metab 2007, 293:E1-E15.
14. Ghosal S., Myers B., Herman J.P. Role of central glucagon-like peptide-1 in stress regulation. Physiol. Behav 2013, 122:201-207.
15. Gil-Lozano M., et al. GLP-1(7-36)-amide and Exendin-4 stimulate the HPA axis in rodents and humans. Endocrinology 2010, 151:2629-2640.
16. Göke R., Larsen P.J., Mikkelsen J.D., Sheikh S.P. Distribution of GLP-1 binding sites in the rat brain: evidence that exendin-4 is a ligand of brain GLP-1 binding sites. Eur. J. Neurosci 1995, 7:2294-2300.
17. Grayson B.E., Seeley R.J., Sandoval D.A. Wired on sugar: the role of the CNS in the regulation of glucose homeostasis. Nat. Rev. Neurosci 2013, 14:24-37.
18. Gustavson S.M., et al. Effects of a long-acting GLP-1 mimetic (PF-04603629) on pulse rate and diastolic blood pressure in patients with type 2 diabetes mellitus. Diabetes Obes. Metab 2011, 13:1056-1058.
19. Hassan M., et al. In vivo dynamic distribution of 131I-glucagon-like peptide-1 (7-36) amide in the rat studied by gamma camera. Nucl. Med. Biol 1999, 26:413-420.
20. Hayes M.R., et al. The common hepatic branch of the vagus is not required to mediate the glycemic and food intake suppressive effects of glucagon-like-peptide-1. Am. J. Physiol. Regul. Integr. Comp. Physiol 2011, 301:R1479-R1485.
21. Hayes M.R., et al. Intracellular signals mediating the food intake-suppressive effects of hindbrain glucagon-like peptide-1 receptor activation. Cell Metab 2011, 13:320-330.
22. Hunter K., Hölscher C. Drugs developed to treat diabetes, liraglutide and lixisenatide, cross the blood brain barrier and enhance neurogenesis. BMC Neurosci 2012, 13:33.
23. Knauf C., et al. Brain glucagon-like peptide-1 increases insulin secretion and muscle insulin resistance to favor hepatic glycogen storage. J. Clin. Invest 2005, 115:3554-3563.
24. Knauf C., et al. Brain glucagon-like peptide 1 signaling controls the onset of high-fat diet-induced insulin resistance and reduces energy expenditure. Endocrinology 2008, 149:4768-4777.
25. Knauf C., et al. Role of central nervous system glucagon-like Peptide-1 receptors in enteric glucose sensing. Diabetes 2008, 57:2603-2612.
26. Kreymann B., Williams G., Ghatei M.A., Bloom S.R. Glucagon-like peptide-1 7-36: a physiological incretin in man. Lancet 1987, 2:1300-1304.
27. Lamont B.J., et al. Pancreatic GLP-1 receptor activation is sufficient for incretin control of glucose metabolism in mice. J. Clin. Invest 2012, 122:388-402.
28. Larsen P.J., Tang-Christensen M., Jessop D.S. Central administration of glucagon-like peptide-1 activates hypothalamic neuroendocrine neurons in the rat. Endocrinology 1997, 138:4445-4455.
29. Larsen P.J., Tang-Christensen M., Holst J.J., Orskov C. Distribution of glucagon-like peptide-1 and other preproglucagon-derived peptides in the rat hypothalamus and brainstem. Neuroscience 1997, 77:257-270.
30. Li B., Xi X., Roane D.S., Ryan D.H., Martin R.J. Distribution of glucokinase, glucose transporter GLUT2, sulfonylurea receptor-1, glucagon-like peptide-1 receptor and neuropeptide Y messenger RNAs in rat brain by quantitative real time RT-PCR. Brain Res. Mol. Brain Res 2003, 113:139-142.
31. Llewellyn-Smith I.J., Reimann F., Gribble F.M., Trapp S. Preproglucagon neurons project widely to autonomic control areas in the mouse brain. Neuroscience 2011, 180:111-121.
32. MacLusky N.J., et al. Neuroendocrine function and response to stress in mice with complete disruption of glucagon-like peptide-1 receptor signaling. Endocrinology 2000, 141:752-762.
33. Mendis B., Simpson E., MacDonald I., Mansell P. Investigation of the haemodynamic effects of exenatide in healthy male subjects. Br. J. Clin. Pharmacol 2012, 74:437-444.
34. Nakabayashi H., Nishizawa M., Nakagawa A., Takeda R., Niijima A. Vagal hepatopancreatic reflex effect evoked by intraportal appearance of tGLP-1. Am. J. Physiol 1996, 271:E808-E813.
35. Parlevliet E.T., de Leeuw van Weenen J.E., Romijn J.A., Pijl H. GLP-1 treatment reduces endogenous insulin resistance via activation of central GLP-1 receptors in mice fed a high-fat diet. Am. J. Physiol. Endocrinol. Metab 2010, 299:E318-E324.
36. Pérez-Tilve D., et al. Exendin-4 increases blood glucose levels acutely in rats by activation of the sympathetic nervous system. Am. J. Physiol. Endocrinol. Metab 2010, 298:E1088-E1096.
37. Richards P., et al. Identification and characterization of GLP-1 receptor-expressing cells using a new transgenic mouse model. Diabetes 2014, 63:1224-1233.
38. Sandoval D., et al. The anorectic effect of GLP-1 in rats is nutrient dependent. PLoS ONE 2012, 7:e51870.
39. Sandoval D.A., Bagnol D., Woods S.C., D'Alessio D.A., Seeley R.J. Arcuate glucagon-like peptide 1 receptors regulate glucose homeostasis but not food intake. Diabetes 2008, 57:2046-2054.
40. Sarkar S., Fekete C., Légrádi G., Lechan R.M. Glucagon like peptide-1 (7-36) amide (GLP-1) nerve terminals densely innervate corticotropin-releasing hormone neurons in the hypothalamic paraventricular nucleus. Brain Res 2003, 985:163-168.
41. Scrocchi L.A., et al. Glucose intolerance but normal satiety in mice with a null mutation in the glucagon-like peptide 1 receptor gene. Nat. Med 1996, 2:1254-1258.
42. Sisley S., Sandoval D. Hypothalamic control of energy and glucose metabolism. Rev. Endocr. Metab. Disord 2011, 12:219-233.
43. Sisley S., et al. Neuronal GLP1R mediates liraglutide's anorectic but not glucose-lowering effect. J. Clin. Invest 2014, 124:2456-2463. 10.1172/JCI72434.
44. Sisley S., Smith K., Sandoval D.A., Seeley R.J. Differences in acute anorectic effects of long-acting GLP-1 receptor agonists in rats. Peptides 2014, 58:1-6.
45. Smith E.P., et al. The role of β cell glucagon-like peptide-1 signaling in glucose regulation and response to diabetes drugs. Cell Metab 2014, 19:1050-1057.
46. Vahl T.P., et al. Glucagon-like peptide-1 (GLP-1) receptors expressed on nerve terminals in the portal vein mediate the effects of endogenous GLP-1 on glucose tolerance in rats. Endocrinology 2007, 148:4965-4973.
47. Villanueva-Peñacarrillo M.L., Alcántara A.I., Clemente F., Delgado E., Valverde I. Potent glycogenic effect of GLP-1(7-36)amide in rat skeletal muscle. Diabetologia 1994, 37:1163-1166.
48. Vrang N., Larsen P.J. Preproglucagon derived peptides GLP-1, GLP-2 and oxyntomodulin in the CNS: role of peripherally secreted and centrally produced peptides. Prog. Neurobiol 2010, 92:442-462.
49. Wan S., Coleman F.H., Travagli R.A. Glucagon-like peptide-1 excites pancreas-projecting preganglionic vagal motoneurons. Am. J. Physiol. Gastrointest. Liver Physiol 2007, 292:G1474-G1482.
50. Wei Y., Mojsov S. Tissue-specific expression of the human receptor for glucagon-like peptide-I: brain, heart and pancreatic forms have the same deduced amino acid sequences. FEBS Lett 1995, 358:219-224.
51. Williams D.L., Baskin D.G., Schwartz M.W. Leptin regulation of the anorexic response to glucagon-like peptide-1 receptor stimulation. Diabetes 2006, 55:3387-3393.